Alcon: FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (1976 to 2026)

Consolidated U.S. FDA 510(k) premarket clearance cohort in Ophthalmic (primary filing hub: TX) reconciled with CDRH and openFDA historical recall notices from 1976 to 2026.

Review 113 FDA 510(k) clearances, 20 recalled K-numbers, and 140 cumulative 1976 to 2026 CDRH recall notices for Alcon on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for Alcon
Regulatory MetricVerified Value
Entity ClassificationConsolidated MedTech Parent (7 FDA applicant names)
Clinical Advisory SpecialtyOphthalmic (Panel OP)
Cleared FDA 510(k) Submissions (1976 to 2026)113 clearances (10 California, 8.8%)
Cleared 510(k)s Linked to a Recall Notice20 K-numbers (17.70% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)140 notices (7 Class I, 132 Class II, 1 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (140 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances2 implantable (1.8%) and 0 life-sustaining
Median FDA 510(k) Review Duration78 days (90th percentile: 209 days)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Alcon across sibling Meru public-data platforms.

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.